ArticleEvidence-based complementary and alternative medicine : eCAM2022

Application of Tivantinib for Hepatocellular Carcinoma: A Meta-Analysis Study.

Guang-Li Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.